RGENREPLIGEN CORPvs its industry peers
A metric-by-metric comparison of REPLIGEN CORP against iShares Biotechnology ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RGEN본 종목 | $10.0B#7 | 242.4x#5 | 4.7x#1 | 13.5x#5 | 16.4%#2 | 291.6%#3 | 7.5%#6 | 2.3%#6 | 2.1%#6 | — | — | — |
| VRTX | $128.8B#3 | 29.6x#3 | 6.4x#2 | 10.7x#4 | 8.9%#4 | 838.1%#2 | 34.8%#1 | 19.5%#4 | 25.0%#3 | — | 31.2%#3 | — |
| AMGN | $208.5B#1 | 24.0x#2 | 17.8x#6 | 5.7x#1 | 10.0%#3 | 88.5%#5 | 24.7%#4 | 66.0%#2 | 15.1%#4 | — | 43.3%#1 | 2.5%#1 |
| GILD | $186.0B#2 | — | 15.7x#5 | 6.3x#2 | 2.4%#5 | 1672.9%#1 | 34.0%#2 | 71.9%#1 | 26.7%#2 | — | 34.9%#2 | 2.2%#2 |
| REGN | — | 19.4x#1 | — | — | 1.0%#6 | 2.1%#7 | 24.9%#3 | 14.2%#5 | 9.4%#5 | — | 31.2%#4 | — |
| ALNY | $32.1B#6 | 41.7x#4 | 23.7x#7 | 8.6x#3 | 65.2%#1 | 212.8%#4 | 13.5%#5 | 23.2%#3 | 150.5%#1 | — | -47.0%#5 | — |
| RVMD | $40.9B#5 | — | 15.7x#4 | — | — | -88.5%#8 | — | -43.4%#8 | — | — | — | — |
| MRNA | $61.5B#4 | — | 9.1x#3 | 31.6x#6 | -39.9%#7 | 20.8%#6 | -158.1%#7 | -41.7%#7 | -54.6%#7 | — | — | — |
Peer set: top holdings of IBB (iShares Biotechnology ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-21.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice